Contrast Induced Nephropathy, Metabolic Syndrome
Conditions
Keywords
creatinine, glomerular filtration rate, metabolic syndrome
Brief summary
Prevention of contrast induced nephropathy after interventional cardiologic procedures deserves close interest because of its association with prolonged hospitalization, increased cost and increased in hospital and long term mortality rates. An observational prospective cohort study was designed to determine whether metabolic syndrome predicts the development of contrast induced nephropathy after elective percutaneous coronary intervention.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
Patients must be scheduled for elective percutaneous coronary intervention Clinical diagnosis of metabolic syndrome Patients must give informed consent
Exclusion criteria
Acute coronary events Acute renal failure End stage renal failure requiring hemodialysis Contrast allergy and exposure to nephrotoxic agent within 1 week before percutaneous coronary intervention Exposure to contrast agent within 1 week before the procedure.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Contrast induced nephropathy | 24-48 hours after the percutaneous coronary intervention | Contrast induced nephropathy was defined as an increase in serum creatinine of \>25% or \>0.5 mg/dl above the baseline value 24 or 48 hours after angiography. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| glomerular filtration rate | 48 hours after the percutaneous coronary intervention | Glomerular filtration rate was estimated using the Cockcroft-Gault formula: (140-age) x weight (kg)/ serum creatinine (mg/dl) x 72 (x 0.85 for females) |
Other
| Measure | Time frame |
|---|---|
| Cut-off point for baseline glomerular filtration rate to predict development of contrast induced nephropathy | baseline glomerular filtration rate |
Countries
Turkey (Türkiye)